For example, the novel dual PI3K/mTOR inhibitor NVP-BEZ235, an orally bioavailable imidazoquinoline derivative, proved to have anti-proliferative effects in several T-ALL cell lines where pro-apoptotic effects were demonstrated (82). The gene discussed is PIK3CD; the disease is acute lymphoblastic leukemia.